These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23192430)

  • 1. Technical Advance: Fluorescent reporter reveals insights into eomesodermin biology in cytotoxic lymphocytes.
    Paley MA; Gordon SM; Bikoff EK; Robertson EJ; Wherry EJ; Reiner SL
    J Leukoc Biol; 2013 Feb; 93(2):307-15. PubMed ID: 23192430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow.
    Daussy C; Faure F; Mayol K; Viel S; Gasteiger G; Charrier E; Bienvenu J; Henry T; Debien E; Hasan UA; Marvel J; Yoh K; Takahashi S; Prinz I; de Bernard S; Buffat L; Walzer T
    J Exp Med; 2014 Mar; 211(3):563-77. PubMed ID: 24516120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-BET and EOMES Accelerate and Enhance Functional Differentiation of Human Natural Killer Cells.
    Kiekens L; Van Loocke W; Taveirne S; Wahlen S; Persyn E; Van Ammel E; De Vos Z; Matthys P; Van Nieuwerburgh F; Taghon T; Van Vlierberghe P; Vandekerckhove B; Leclercq G
    Front Immunol; 2021; 12():732511. PubMed ID: 34630413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential transcription of Eomes and T-bet during maturation of mouse uterine natural killer cells.
    Tayade C; Fang Y; Black GP; V A P; Erlebacher A; Croy BA
    J Leukoc Biol; 2005 Dec; 78(6):1347-55. PubMed ID: 16204645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage-Specific Requirement for Eomes in Mature NK Cell Homeostasis and Cytotoxicity.
    Wagner JA; Wong P; Schappe T; Berrien-Elliott MM; Cubitt C; Jaeger N; Lee M; Keppel CR; Marin ND; Foltz JA; Marsala L; Neal CC; Sullivan RP; Schneider SE; Keppel MP; Saucier N; Cooper MA; Fehniger TA
    Cell Rep; 2020 Jun; 31(9):107720. PubMed ID: 32492428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of eomesodermin and T-bet expression by allostimulated CD8
    Perez-Gutierrez A; Metes DM; Lu L; Hariharan S; Thomson AW; Ezzelarab MB
    Clin Exp Immunol; 2018 Nov; 194(2):259-272. PubMed ID: 30246373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation.
    Gordon SM; Chaix J; Rupp LJ; Wu J; Madera S; Sun JC; Lindsten T; Reiner SL
    Immunity; 2012 Jan; 36(1):55-67. PubMed ID: 22261438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous antigen presentation impacts on T-box transcription factor expression and functional maturation of CD8+ T cells.
    Smith C; Elhassen D; Gras S; Wynn KK; Dasari V; Tellam J; Tey SK; Rehan S; Liu YC; Rossjohn J; Burrows SR; Khanna R
    Blood; 2012 Oct; 120(16):3237-45. PubMed ID: 22942184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectopic expression of a T-box transcription factor, eomesodermin, renders CD4(+) Th cells cytotoxic by activating both perforin- and FasL-pathways.
    Eshima K; Chiba S; Suzuki H; Kokubo K; Kobayashi H; Iizuka M; Iwabuchi K; Shinohara N
    Immunol Lett; 2012 May; 144(1-2):7-15. PubMed ID: 22425747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable prognostic influence of T-box transcription factor Eomesodermin in metastatic renal cell cancer patients.
    Dielmann A; Letsch A; Nonnenmacher A; Miller K; Keilholz U; Busse A
    Cancer Immunol Immunother; 2016 Feb; 65(2):181-92. PubMed ID: 26753694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eomesodermin spatiotemporally orchestrates the early and late stages of NK cell development by targeting KLF2 and T-bet, respectively.
    He J; Chen D; Xiong W; Hou X; Quan Y; Yang M; Dong Z
    Cell Mol Immunol; 2024 Jul; 21(7):662-673. PubMed ID: 38740922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-bet and Eomes govern differentiation and function of mouse and human NK cells and ILC1.
    Zhang J; Marotel M; Fauteux-Daniel S; Mathieu AL; Viel S; Marçais A; Walzer T
    Eur J Immunol; 2018 May; 48(5):738-750. PubMed ID: 29424438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eomesodermin controls a unique differentiation program in human IL-10 and IFN-γ coproducing regulatory T cells.
    Gruarin P; Maglie S; De Simone M; Häringer B; Vasco C; Ranzani V; Bosotti R; Noddings JS; Larghi P; Facciotti F; Sarnicola ML; Martinovic M; Crosti M; Moro M; Rossi RL; Bernardo ME; Caprioli F; Locatelli F; Rossetti G; Abrignani S; Pagani M; Geginat J
    Eur J Immunol; 2019 Jan; 49(1):96-111. PubMed ID: 30431161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of KIR + NKG2A + Eomes- NK-like CD8+ T cells and their decline with age in healthy individuals.
    Kasakovski D; Zeng X; Lai J; Yu Z; Yao D; Chen S; Zha X; Li Y; Xu L
    Cytometry B Clin Cytom; 2021 Jul; 100(4):467-475. PubMed ID: 32830898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription analysis of two Eomesodermin genes in lymphocyte subsets of two teleost species.
    Takizawa F; Araki K; Ohtani M; Toda H; Saito Y; Lampe VS; Dijkstra JM; Ototake M; Moritomo T; Nakanishi T; Fischer U
    Fish Shellfish Immunol; 2014 Jan; 36(1):215-22. PubMed ID: 24239596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling.
    Grange M; Verdeil G; Arnoux F; Griffon A; Spicuglia S; Maurizio J; Buferne M; Schmitt-Verhulst AM; Auphan-Anezin N
    J Immunol; 2013 Oct; 191(7):3712-24. PubMed ID: 24006458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting Edge: Eomesodermin Is Sufficient To Direct Type 1 Innate Lymphocyte Development into the Conventional NK Lineage.
    Pikovskaya O; Chaix J; Rothman NJ; Collins A; Chen YH; Scipioni AM; Vivier E; Reiner SL
    J Immunol; 2016 Feb; 196(4):1449-54. PubMed ID: 26792802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for eomesodermin-expressing innate-like CD8(+) KIR/NKG2A(+) T cells in human adults and cord blood samples.
    Jacomet F; Cayssials E; Basbous S; Levescot A; Piccirilli N; Desmier D; Robin A; Barra A; Giraud C; Guilhot F; Roy L; Herbelin A; Gombert JM
    Eur J Immunol; 2015 Jul; 45(7):1926-33. PubMed ID: 25903796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRTAM determines the CD4+ cytotoxic T lymphocyte lineage.
    Takeuchi A; Badr Mel S; Miyauchi K; Ishihara C; Onishi R; Guo Z; Sasaki Y; Ike H; Takumi A; Tsuji NM; Murakami Y; Katakai T; Kubo M; Saito T
    J Exp Med; 2016 Jan; 213(1):123-38. PubMed ID: 26694968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting edge: The transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche.
    Banerjee A; Gordon SM; Intlekofer AM; Paley MA; Mooney EC; Lindsten T; Wherry EJ; Reiner SL
    J Immunol; 2010 Nov; 185(9):4988-92. PubMed ID: 20935204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.